Related Experiment Video
Updated: Oct 17, 2025

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.3K
Intraabdominal and ganglionic desmoplastic small round cell tumor: a case series
S Slim1,2, I Zemni3,4,5, A Bouida3,4
1Surgical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia. slim.skander@gmail.com.
Journal of Medical Case Reports
|October 12, 2021
Summary
Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive cancer in young males. Multidisciplinary treatment offers little hope, as DSRCT remains lethal despite aggressive therapies.
Area of Science:
- Oncology
- Rare Cancers
- Sarcomas
Background:
- Desmoplastic small round cell tumor (DSRCT) is a rare malignancy with a poor prognosis, primarily affecting young males.
- DSRCT often presents as a large abdominal mass with extensive peritoneal spread at diagnosis.
- Metastatic disease can occur in advanced stages of DSRCT.
Observation:
- This study retrospectively analyzed four cases of DSRCT in young North African males.
- Cases involved intra-abdominal masses and one case with ganglionic involvement without a discernible mass.
- All cases were confirmed by the characteristic t(11;22) translocation.
Findings:
- Treatment involved a multidisciplinary approach including surgery, chemotherapy, and radiotherapy.
- Despite aggressive multimodal therapy, including high-dose chemotherapy and extensive resection, outcomes remained poor.
- One patient with ganglionic DSRCT showed no response to chemotherapy and was lost to follow-up.
Implications:
- Current treatment paradigms for DSRCT, while multidisciplinary, are largely insufficient to overcome the disease's lethality.
- The findings underscore the urgent need for developing more effective therapeutic strategies for DSRCT.
- Further research into the molecular mechanisms and novel treatment modalities for DSRCT is critical.
